Ubs Group Ag Ironwood Pharmaceuticals Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Group Ag holds 11,200,320 shares of IRWD stock, worth $51.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,200,320

Previous 11,200,320 -0.0%

Holding current value

$51.6 Million

Previous $73 Million 36.96%

% of portfolio

0.01%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.93 - $7.04 $3.51 Million - $6.29 Million	-892,915 Reduced 48.53%	946,884 $3.89 Million
Q2 2024 Aug 13, 2024	SELL	$5.58 - $8.61 $6.63 Million - $10.2 Million	-1,187,916 Reduced 39.23%	1,839,799 $12 Million
Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $21.5 Million - $39.9 Million	2,582,407 Added 579.91%	3,027,715 $26.4 Million
Q4 2023 Feb 09, 2024	SELL	$8.79 - $11.51 $3.95 Million - $5.18 Million	-449,766 Reduced 50.25%	445,308 $5.09 Million
Q3 2023 Nov 09, 2023	BUY	$8.25 - $11.35 $1.71 Million - $2.36 Million	207,756 Added 30.23%	895,074 $8.62 Million
Q2 2023 Aug 11, 2023	SELL	$10.1 - $11.6 $1.01 Million - $1.16 Million	-99,766 Reduced 12.68%	687,318 $7.31 Million
Q1 2023 May 12, 2023	SELL	$10.37 - $12.56 $344,252 - $416,954	-33,197 Reduced 4.05%	787,084 $8.28 Million
Q4 2022 Feb 08, 2023	BUY	$9.9 - $12.43 $7.05 Million - $8.86 Million	712,596 Added 661.74%	820,281 $10.2 Million
Q3 2022 Nov 10, 2022	SELL	$10.14 - $12.38 $96,005 - $117,213	-9,468 Reduced 8.08%	107,685 $1.12 Million
Q2 2022 Aug 10, 2022	SELL	$11.05 - $12.72 $3.46 Million - $3.98 Million	-313,078 Reduced 72.77%	117,153 $1.35 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $297,790 - $361,502	-28,067 Reduced 6.12%	430,231 $5.41 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $1.78 Million - $2.29 Million	-164,359 Reduced 26.4%	458,298 $5.35 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $2.76 Million - $3.22 Million	231,156 Added 59.04%	622,657 $8.13 Million
Q2 2021 Aug 13, 2021	BUY	$10.16 - $13.11 $3.89 Million - $5.02 Million	383,281 Added 4662.79%	391,501 $5.04 Million
Q1 2021 May 12, 2021	BUY	$9.04 - $11.86 $18,703 - $24,538	2,069 Added 33.64%	8,220 $92,000
Q4 2020 Feb 11, 2021	SELL	$9.05 - $12.2 $539,742 - $727,608	-59,640 Reduced 90.65%	6,151 $70,000
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $581,958 - $695,243	-64,734 Reduced 49.6%	65,791 $592,000
Q2 2020 Jul 31, 2020	SELL	$9.14 - $11.97 $2.95 Million - $3.86 Million	-322,425 Reduced 71.18%	130,525 $1.35 Million
Q1 2020 May 01, 2020	SELL	$8.58 - $14.01 $2.62 Million - $4.29 Million	-305,929 Reduced 40.31%	452,950 $4.57 Million
Q4 2019 Feb 14, 2020	SELL	$8.22 - $14.0 $1.45 Million - $2.47 Million	-176,735 Reduced 18.89%	758,879 $10.1 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $4.41 Million - $5.62 Million	513,070 Added 121.42%	935,614 $8.03 Million
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $197,558 - $259,849	20,159 Added 5.01%	422,544 $4.62 Million
Q1 2019 May 14, 2019	SELL	$8.27 - $12.73 $3.8 Million - $5.85 Million	-459,417 Reduced 53.31%	402,385 $4.56 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $1.1 Million - $2.28 Million	141,479 Added 19.64%	861,802 $8.93 Million
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $7.16 Million - $8.83 Million	500,287 Added 227.37%	720,323 $13.3 Million
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $769,884 - $1.05 Million	65,079 Added 42.0%	220,036 $4.21 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $1.49 Million - $1.82 Million	133,641 Added 626.95%	154,957 $2.39 Million
Q4 2017 Feb 14, 2018	SELL	$12.16 - $14.58 $362,684 - $434,863	-29,826 Reduced 58.32%	21,316 $319,000
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $466,360 - $574,547	38,638 Added 309.01%	51,142 $807,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,051 Added 2660.26%	12,504 $236,000
Q1 2017 Nov 14, 2017	BUY	N/A	453	453 $8,000

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $706M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account